Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMYGet Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.39, but opened at $12.80. Terumo shares last traded at $12.79, with a volume of 41,690 shares.

Analyst Ratings Changes

Separately, Nomura upgraded shares of Terumo to a “hold” rating in a report on Tuesday, February 24th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

View Our Latest Analysis on Terumo

Terumo Price Performance

The firm has a fifty day moving average of $13.57 and a 200 day moving average of $15.36. The company has a current ratio of 1.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $18.93 billion, a P/E ratio of 22.12 and a beta of 0.74.

Terumo (OTCMKTS:TRUMYGet Free Report) last announced its quarterly earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Terumo had a net margin of 11.74% and a return on equity of 9.01%. The company had revenue of $1.94 billion for the quarter, compared to analysts’ expectations of $1.82 billion.

Terumo Company Profile

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

See Also

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.